Wall Street Analysts See a 50.5% Upside in AngioDynamics (ANGO): Can the Stock Really Move This High?

AngioDynamics (ANGO) has a mean analyst price target implying 50.5% upside, signaling positive analyst expectations for the stock. The article notes that rising earnings estimates across analysts also support a bullish view, even though price targets alone have historically been an imperfect predictor. This is constructive for sentiment but likely limited in immediate price impact.

Analysis

AngioDynamics (ANGO) has a mean analyst price target implying 50.5% upside, signaling positive analyst expectations for the stock. The article notes that rising earnings estimates across analysts also support a bullish view, even though price targets alone have historically been an imperfect predictor. This is constructive for sentiment but likely limited in immediate price impact.